Pathways Knowlegdes
Biological pathway database
| Pathway | DOIs | Note |
|---|---|---|
| Sphingolipid metabolism overview Accession ID: WikiPathways:WP4725 |
|
Le Stunff H, Peterson C, Thornton R, Milstien S, Mandala SM, Spiegel S. Characterization of Murine Sphingosine-1-phosphate Phosphohydrolase. Journal of Biological Chemistry. 2002 Mar;277(11):8920–7. doi: 10.1074/jbc.m109968200. |
| Sphingolipid pathway Accession ID: WikiPathways:WP1422 |
|
Merrill AH, Stokes TH, Momin A, Park H, Portz BJ, Kelly S, Wang E, Sullards MC, Wang MD. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. Journal of Lipid Research. 2009 Apr;50():S97–S102. doi: 10.1194/jlr.r800073-jlr200. |
| Biochemical pathways: part I Accession ID: WikiPathways:WP3604 |
|
Michal G. On representation of metabolic pathways. Biosystems. 1998 Jun;47(1-2):1–7. doi: 10.1016/s0303-2647(98)00019-7. PMID: 9715748. |
| Sphingolipid metabolism (integrated pathway) Accession ID: WikiPathways:WP4690 |
|
Dennis EA, Deems RA, Harkewicz R, Quehenberger O, Brown HA, Milne SB, Myers DS, Glass CK, Hardiman G, Reichart D, Merrill AH, Sullards MC, Wang E, Murphy RC, Raetz CRH, Garrett TA, Guan Z, Ryan AC, Russell DW, McDonald JG, Thompson BM, Shaw WA, Sud M, Zhao Y, Gupta S, Maurya MR, Fahy E, Subramaniam S. A Mouse Macrophage Lipidome. Journal of Biological Chemistry. 2010 Dec;285(51):39976–85. doi: 10.1074/jbc.m110.182915. |
| Sphingolipid metabolism Accession ID: WikiPathways:WP3232 |
|
Merrill AH, Wang MD, Park M, Sullards MC. (Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends Biochem Sci. 2007 Oct;32(10):457–68. doi: 10.1016/j.tibs.2007.09.004. PMID: 17928229. |
| Sphingolipid metabolism overview Accession ID: WikiPathways:WP4344 |
|
Merrill AH. De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway. Journal of Biological Chemistry. 2002 Jul;277(29):25843–6. doi: 10.1074/jbc.r200009200. |
| SARS-CoV-2 and COVID-19 pathway Accession ID: WikiPathways:WP4846 |
|
Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. Journal of Medical Virology. 2020 Mar 16;92(6):660–6. doi: 10.1002/jmv.25754. |
| Synthesis of ceramides and 1-deoxyceramides Accession ID: WikiPathways:WP5194 |
|
Sen P, Hyötyläinen T, Orešic M. 1-Deoxyceramides - Key players in lipotoxicity and progression to type 2 diabetes? Acta Physiol (Oxf). 2021 May;232(1):e13635. doi: 10.1111/apha.13635. PMID: 33630410. |
| Sphingolipid metabolism: integrated pathway Accession ID: WikiPathways:WP4726 |
|
Mizutani Y, Kihara A, Igarashi Y. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J. 2005 Aug 15;390(Pt 1):263–71. PMID: 15823095; PMCID: PMC1184580. |
| GDNF signaling Accession ID: WikiPathways:WP5143 |
|
Baloh RH, Tansey MG, Golden JP, Creedon DJ, Heuckeroth RO, Keck CL, Zimonjic DB, Popescu NC, Johnson EM, Milbrandt J. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron. 1997 May;18(5):793–802. doi: 10.1016/s0896-6273(00)80318-9. PMID: 9182803. |